Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Lilly's newest antipicornavirus agents

Sep. 27, 1996

Positive phase III results with AmBisome to be included in NDA filing

Sep. 27, 1996

High clinical efficacy reported for Penederm's Mentax antifungal product

Sep. 27, 1996

Novel antifungal antibiotic reported by German and Swedish researchers

Sep. 27, 1996

Takeda discloses anti-Ureaplasma agents

Sep. 27, 1996

U.S. and Canadian researchers report fungicidal conjugated styryl ketones

Sep. 27, 1996

Bayer claims naphthyridine derivatives

Sep. 27, 1996

Generic cefaclor approved in the U.S.

Sep. 27, 1996

Takeda develops new pediatric formulation of Firstcin

Sep. 27, 1996

New tablet formulation of valaciclovir

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...